Key result
Radiofrequency ablation reverses tachycardia-induced cardiomyopathy, improving LVEF by ~43 percentage points.
Case Report (n=1)
No
Early electroanatomical mapping and precise radiofrequency ablation can completely reverse severe, drug-refractory tachycardia-induced cardiomyopathy in pediatric patients.
Answers are grounded in this paper and cite their sources.
May support ablation for reversible pediatric cardiomyopathy; hypothesis-generating from single case and requires prospective validation.
Tachycardia-induced cardiomyopathy secondary to persistent tachycardia in children is a distinct form of cardiomyopathy caused by sustained or frequent tachyarrhythmias. It is characterized by cardiac enlargement, impaired cardiac function, and heart failure and is clinically reversible with early and standardized treatment. Herein, we report a challenging pediatric case presenting with recurrent intermittent dyspnea and palpitations for 1 year. The final diagnoses were as follows: (a) paroxysmal atrial tachycardia and (b) tachycardia-induced cardiomyopathy. Under the guidance of a three-dimensional electroanatomical mapping system, an intracardiac electrophysiological study accurately localized the focal atrial tachycardia to the posterior margin of the right upper pulmonary vein, followed by successful radiofrequency ablation. The patient's clinical symptoms improved significantly postoperatively, and the patient was discharged uneventfully. During the 8-month follow-up period, no recurrence of atrial tachycardia was documented. Follow-up echocardiography confirmed normalization of cardiac dimensions and function.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) conducted a case report in Tachycardia-induced cardiomyopathy (TIC) secondary to paroxysmal atrial tachycardia (n=1). Radiofrequency ablation was evaluated on Termination of tachycardia and recovery of left ventricular systolic function. Radiofrequency ablation successfully terminated focal atrial tachycardia and completely reversed tachycardia-induced cardiomyopathy, improving ejection fraction from 16% to 59% at 8 months.
Synapse has enriched 10 related papers. Consider them for comparative context: